Earlybird is a European venture investor backing pre-seed to Series A founders in emerging technology. Its stated remit ranges from fintech to deep tech and health, with offices across several European hubs.
At a glance
Investment focus
Source and review
Profile reviewed on . Research reviewed by the EverythingVC Editorial Team.
European mandate
- Geographic fit
- European early-stage technology companies
- Round behaviour
- Day-one partner through follow-on rounds
Founder fit
- Strongest documented fit
- Designed for European emerging-technology founders from pre-seed through Series A, with seed representing the largest share of the firm's published new-investment mix. The remit reaches from fintech and enterprise AI to deep tech, health and other technically ambitious categories.
- Limits and questions to verify
- The published EUR 12 million figure is a maximum initial ticket, not a typical cheque for every round. Founders should also distinguish Earlybird's core early-stage proposition from specialist vehicles and the separate 2026 dual-use and defence growth initiative.
- Active-fund and deployment evidence
- Earlybird's current site states the European remit, pre-seed-to-Series-A mix, maximum initial ticket and recent investment pace; its 2025 review provides recent examples of led European pre-seed and seed rounds.
